Tamoxifen Protects from Vesicular Stomatitis Virus Infection

• Main Authors: Lamin B. Cham (Author), Sarah-Kim Friedrich (Author), Tom Adomati (Author), Hilal Bhat (Author), Maximilian Schiller (Author), Michael Bergerhausen (Author), Thamer Hamdan (Author), Fanghui Li (Author), Yara Maria Machlah (Author), Murtaza Ali (Author), Vikas Duhan (Author), Karl Sebastian Lang (Author), Justa Friebus-Kardash (Author), Judith Bezgovsek (Author)
• Format: Book
• Published: MDPI AG, 2019-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Tamoxifen (TAM) is an estrogen-receptor antagonist, widely used in the adjuvant treatment of early stage estrogen-sensitive breast cancer. Several studies have revealed new biological targets of TAM that mediate the estrogen receptor independent activities of the drug. Recently, the anti...